# Bas Groot Koerkamp

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bas-groot-koerkamp/

## Facts

| Field | Value |
| --- | --- |
| Citations | 29,556 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 82 |
| i10-index | 388 |
| Last Known Institution | Erasmus MC |
| OpenAlex ID | https://openalex.org/A5027294559 |
| ORCID iD | 0000-0003-1917-6973 |
| Works | 1,036 |

## Researcher papers

Showing 12 of 16.

- [Cholangiocarcinoma 2020: the next horizon in mechanisms and management](https://scholariq.org/papers/cholangiocarcinoma-2020-the-next-horizon-in-mechanisms-and-management/)
- [Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial](https://scholariq.org/papers/preoperative-chemoradiotherapy-versus-immediate-surgery-for-resectable-and/)
- [FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis](https://scholariq.org/papers/folfirinox-for-locally-advanced-pancreatic-cancer-a-systematic-review-and/)
- [Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD)](https://scholariq.org/papers/minimally-invasive-versus-open-distal-pancreatectomy-leopard/)
- [Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial](https://scholariq.org/papers/laparoscopic-versus-open-pancreatoduodenectomy-for-pancreatic-or-periampullary/)
- [Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer](https://scholariq.org/papers/meta-analysis-comparing-upfront-surgery-with-neoadjuvant-treatment-in-patients/)
- [Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS)](https://scholariq.org/papers/alternative-fistula-risk-score-for-pancreatoduodenectomy-a-frs/)
- [Pancreatic cancer](https://scholariq.org/papers/pancreatic-cancer/)
- [Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry](https://scholariq.org/papers/cholangiocarcinoma-landscape-in-europe-diagnostic-prognostic-and-therapeutic/)
- [Surgery for cholangiocarcinoma](https://scholariq.org/papers/surgery-for-cholangiocarcinoma/)
- [Benchmarks in Pancreatic Surgery](https://scholariq.org/papers/benchmarks-in-pancreatic-surgery/)
- [Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis](https://scholariq.org/papers/neoadjuvant-folfirinox-in-patients-with-borderline-resectable-pancreatic-cancer/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)
- [Pancreatitis Pathology and Treatment](https://scholariq.org/topics/pancreatitis-pathology-and-treatment/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Researcher university

- [Erasmus MC](https://scholariq.org/institutions/erasmus-mc/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.